SOLUBLE LYMPHOTOXIN-BETA RECEPTORS, ANTI-LYMPHOTOXIN RECEPTOR ANTIBODIES, AND ANTI-LYMPHOTOXIN LIGAND ANTIBODIES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASES
摘要
<p>Compositions and methods comprising 'lymphotoxin-β receptor blocking agents' which block lymphotoxin-ß receptor signalling and are useful for altering immunological diseases, and particularly antibody mediated immune responses.</p>
